Keywords: ایمونوتراپی سرطان; Exosomes; Cancer immunotherapy; Adaptive immunity; Innate immunity; Dendritic cells;
مقالات ISI ایمونوتراپی سرطان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوتراپی سرطان; Bioresorbable polymer; Cancer immunotherapy; Emulsion disintegration; Tumor-associated antigen; Vaccine adjuvant;
Keywords: ایمونوتراپی سرطان; cancer immunotherapy; dendritic cells; monocytes
Keywords: ایمونوتراپی سرطان; pH-sensitive liposome; Cationic lipid; Cancer immunotherapy; Adjuvant; Dendritic cell; Cellular immunity
Keywords: ایمونوتراپی سرطان; Tumour-associated macrophages; Cancer immunotherapy; Macrophage mannose receptor; Bletilla striata polysaccharide; Glucomannan; Bisphosphonate
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Personalized medicine; Tumor antigens; Predictive biomarkers; Tumor heterogeneity; Adoptive T cell therapy;
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Powder-form adjuvant; Immunostimulation; Hyaluronic acid; Cellular immunity
CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy
Keywords: ایمونوتراپی سرطان; CRISPR/CAS9; Cancer immunotherapy; Chimeric antigen receptor; TCR; Adoptive immunotherapy;
Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo
Keywords: ایمونوتراپی سرطان; Long-acting fusion protein; Antitumor; Cancer immunotherapy; Immunoregulation;
Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates
Keywords: ایمونوتراپی سرطان; Colorectal carcinoma; Cancer stem cells; Vaccine; MUC1; Cancer immunotherapy;
Polyactin A is a novel and potent immunological adjuvant for peptide-based cancer vaccine
Keywords: ایمونوتراپی سرطان; Polyactin A; Immune adjuvant; Peptide-base cancer vaccine; Cancer immunotherapy; Tumor-associated antigen;
Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safety
Keywords: ایمونوتراپی سرطان; Adoptive cell therapy; Chimeric antigen receptor; Engineering; Cancer immunotherapy;
Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy
Keywords: ایمونوتراپی سرطان; Chimeric antigen receptor T cells; Chimeric nucleases; Cancer immunotherapy;
Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study
Keywords: ایمونوتراپی سرطان; Anti-PD-L1; Cancer immunotherapy; Docetaxel; Japan; TECENTRIQ;
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Immune checkpoint blockade; CTLA-4; PD-1; PD-L1;
Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis
Keywords: ایمونوتراپی سرطان; Melanoma B16-F10; Panc02; TLR agonists; Phagocytosis; Cancer immunotherapy; Metastasis;
Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells
Keywords: ایمونوتراپی سرطان; adHER2/neu; cancer immunotherapy; dendritic cells (DCs);
Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer
Keywords: ایمونوتراپی سرطان; Ad; adenovirus; HPV; human papilloma virus; IFN-γ; interferon γ; IL1β; Interleukin 1β; MG1; MG1 strain of Maraba virus; MOI; multiplicity of infection; OV; oncolytic virus; PBMC; peripheral blood mononuclear cell; SLP; synthetic long peptide; TAA; tum
A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21
Keywords: ایمونوتراپی سرطان; CAR T cells; cancer immunotherapy; IL-4; IL-7; IL-21; piggyBac transposon;
T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics
Keywords: ایمونوتراپی سرطان; CRS; cytokine release syndrome; CTL; cytotoxic T lymphocyte; EC50; half maximal effective concentration; Fc; fragment crystallizable; ICI; immune checkpoint inhibitor; pMHC; peptide-major histocompatibility complex; scFv; single chain variable fragment; T
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?
Keywords: ایمونوتراپی سرطان; Cyclophosphamide (PubChem CID: 2907); DTIC (Dacarbazine) (PubChem CID: 5353562); GPI 15427 (PubChem CID: 11739525); Lomeguatrib (PubChem CID: 3025944); NU 1025 (PubChem CID: 63306); Temozolomide (PubChem CID: 5394); BER; base excision repair; CD2F1; hybri
Solubility-enhanced gMYL6 fused with a hexa-lysine tag promotes the cytotoxicity of human NK cells
Keywords: ایمونوتراپی سرطان; gMYL6; goat myosin light chain 6; ACBPs; anti-cancer bioactive peptides; NK; natural killer; UCB; umbilical cord blood; HSCs; hematopoietic stem cells; gPRDX5; goat peroxiredoxin-5; BabA; blood group antigen-binding adhesion; Amp; ampicillin; IPTG; iso-pr
Cardiac Profile of Chimeric Antigen Receptor T Cell Therapy in Children: A Single-Institution Experience
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Chimeric antigen receptor T cell; Cardiac effects; Pediatric;
MAGE-A antigens as targets for cancer immunotherapy
Keywords: ایمونوتراپی سرطان; Cancer testis antigens; MAGE; Cancer immunotherapy; Adoptive T cell therapy;
Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy
Keywords: ایمونوتراپی سرطان; Glutathione depletion; ROS generation; Tetrasulfide-bridged organosilica; Cancer immunotherapy; Co-delivery;
Two tandem repeats of mHSP70407-426 enhance therapeutic antitumor effects of a recombined vascular endothelial growth factor (VEGF) protein vaccine
Keywords: ایمونوتراپی سرطان; mHSP70407-426; VEGF; Cancer vaccine; Anti-angiogenesis; Cancer immunotherapy;
Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors
Keywords: ایمونوتراپی سرطان; Indoleamine 2,3-dioxygenase 1; Cancer immunotherapy; Naphthoindolizine; Indolizinoquinoline-5,12-dione derivatives;
Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
Keywords: ایمونوتراپی سرطان; STING agonist; PBAE nanoparticle formulation; Cancer immunotherapy; CDNs; Cyclic dinucleotides; STING; Stimulator of Interferon Receptor; PBAEs; poly(beta-amino ester)s; IFN; interferon; SEAP; secreted embryonic alkaline phosphatase; cGAS; cyclic GMP-AMP
The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy
Keywords: ایمونوتراپی سرطان; αβ; alpha beta; ADCC; antibody-dependent cellular cytotoxicity; APC; antigen-presenting cell; BrHPP; bromohydrin pyrophosphate; BTLA; B and T lymphocyte attenuator; CAR; chimeric antigen receptor; DC; dendritic cell; γc; common gamma; γδ; gamma delta
Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; CTLA-4; Hybrid nanoparticles; Imatinib; tLyp1 peptide; Treg cell;
Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Microneedles; DNA vaccines; Poly(I:C); pH-sensitive copolymers;
Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist
Keywords: ایمونوتراپی سرطان; Nanoparticles; Papaya mosaic virus; Plasmacytoid dendritic cells; TLR7; TLR8 adjuvant; Cancer immunotherapy; PapMV; papaya mosaic virus; ssRNA; single stranded RNA; VLNP; virus-like nanoparticles; CP; coat protein; PBMC; peripheral blood mononuclear cells
Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors
Keywords: ایمونوتراپی سرطان; Indoleamine 2,3-dioxygenase 1; Cancer immunotherapy; Naphthoquinone derivatives; Tryptophan 2,3-dioxygenase;
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
Keywords: ایمونوتراپی سرطان; Atezolizumab; PD-L1; Checkpoint inhibitor; Non-small cell lung cancer; Cancer immunotherapy;
Structural insights into the binding mechanism of IDO1 with hydroxylamidine based inhibitor INCB14943
Keywords: ایمونوتراپی سرطان; Indoleamine 2, 3-dioxygenase 1; INCB14943; Cancer immunotherapy; Halogen bond;
Conditioning neoadjuvant therapies for improved immunotherapy of cancer
Keywords: ایمونوتراپی سرطان; Targeted drug delivery; Nanoparticles; Cancer immunotherapy; Neoadjuvant therapy;
Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome
Keywords: ایمونوتراپی سرطان; Constitutional mismatch repair deficiency syndrome; CMMRD; Neoantigens; Cancer immunotherapy; Prevention; CMMRD; constitutional mismatch repair deficiency; COX; cyclooxygenase; CRC; colorectal cancer; CTLs; cytotoxic T lymphocytes; GBM; glioblastoma multi
Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer
Keywords: ایمونوتراپی سرطان; PC; prostate cancer; DC; dendritic cell; FITC; fluorescein isothiocyanate; mGM-CSF; mouse granulocyte macrophage colony-stimulating factor; PBS; PHOSPHATE buffered saline; SA; streptavidin; Tregs; regulatory T cells; ICOS; inducible costimulator; Foxp3; f
Combined blockade of Tim-3 and MEK inhibitor enhances the efficacy against melanoma
Keywords: ایمونوتراپی سرطان; Trametinib; Tim-3; MAPK pathway; Targeted therapy; Cancer immunotherapy; MAPK; mitogen-activated protein kinase; MEK; mitogen-activated extracellular signal-regulated kinase; OS; overall survival; CTLA-4; cytotoxic T lymphocyte antigen-4; PD-1; programmed
Mini-reviewmTOR signaling in immune cells and its implications for cancer immunotherapy
Keywords: ایمونوتراپی سرطان; mTOR-mediated metabolism; mTORC1; mTORC2; Goldilocks mTOR; Cancer immunotherapy;
Advances in CRISPR-Cas based genome engineering
Keywords: ایمونوتراپی سرطان; CRISPR-Cas9; Genome engineering; Organoids; High throughput genetic screens; Cancer immunotherapy; Gene therapy;
Original ResearchComparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas
Keywords: ایمونوتراپی سرطان; Programmed death-ligand 1; Pulmonary adenocarcinoma; Immune checkpoint; PD-1 blockade; Cancer immunotherapy;
Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis
Keywords: ایمونوتراپی سرطان; Exosome; Cancer immunotherapy; CD47; Signal regulatory protein α; Phagocytosis;
IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation
Keywords: ایمونوتراپی سرطان; Natural killer cells; Cytokine stimulation; Cancer immunotherapy; Innate immunity;
Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies
Keywords: ایمونوتراپی سرطان; Vaccination; DOTAP; DOSS; PLGA; Cancer immunotherapy; Charged microparticles; Adjuvants;
ReviewCancer immunotherapy targeting the CD47/SIRPα axis
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Immune checkpoint; Immuno-oncology; CD47; SIRPa; Macrophage; Phagocytosis;
Chronic stress suppresses anti-tumor TCD8+ responses and tumor regression following cancer immunotherapy in a mouse model of melanoma
Keywords: ایمونوتراپی سرطان; Chronic stress; Social disruption stress (SDR); Cancer immunotherapy; DC-based vaccines; Cytotoxic T cells;
A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy
Keywords: ایمونوتراپی سرطان; Cancer immunotherapy; Foreignization; Antigen delivery; Hyaluronic acid; PEGylation; Matrix metalloproteinase 9 (MMP9);
TLR7 and TLR8 agonist resiquimod (R848) differently regulates MIF expression in cells and organs
Keywords: ایمونوتراپی سرطان; Resiquimod (R848); Macrophage migration inhibitory factor (MIF); Organs; Cellular microenvironment; Cancer immunotherapy;
pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA
Keywords: ایمونوتراپی سرطان; pH-sensitive liposome; Adjuvant; Cationic lipid; CpG-DNA; Cancer immunotherapy; Dendritic cell;